Conectar con nosotros

EU

100 milioi gaixoen potentzial 'ez ondo informatuta' mugaz gaindiko osasun aukerei buruzko

PARTEKATU:

Argitaratutako

on

Zure erregistroa baimendutako moduetan edukia eskaintzeko eta zure ezagutza hobetzeko erabiltzen dugu. Harpidetza edozein unetan har dezakezu.

20150422PHT44602_originalBy Europako Aliantza Medikuntza Pertsonalizatuko for Zuzendari Exekutiboa Denis Horgan

A major survey undertaken on behalf of the European Commission has shown that the experience of cross-border health care in the EU has changed little since 2007.

This is despite the implementation of a Directive on patients’ rights in cross-border health care more than a year prior to the poll.

iragarki

Back in 2011, a directive proposed by the Commission on the application of patients’ rights in cross-border health-care was adopted by the European Parliament and the European Council. The directive entered into force at the end of 2013 across all member states.  Its objectives were to provide clear rules and reliable information to patients regarding access and reimbursement for healthcare received in another EU country, “to meet patients' expectations of the highest-quality health care when travelling abroad and to ensure EU countries work closer together in the interest of patients”.

For the report, nearly 28,000 people, coming from different social and demographic groups, were interviewed across all 28 member states at the end of October 2014, on behalf of the Commission’s Directorate-General for Health and Consumers (SANCO).  It found that one-in-twenty patients said they had experienced medical treatment in another EU country in the last year, which equates to an increase of just 1% on 2007.

Yet around half would be willing to travel to another EU country for medical treatment with the most common reasons for patients doing so being to receive treatment unavailable in their own member state and/or to receive better quality treatment.  Indeed, in 26 of the 28 member states, the key reason given by people was to receive treatment that is not available in their own country although, in two countries, this came after the desire to receive better quality treatment.

iragarki

Countries where people were the most open to cross-border health care tended to be those living in smaller countries, such as Malta, the Netherlands, Cyprus, Denmark and Luxembourg. Patients were least prepared to seek treatment abroad in Germany, Finland, France and Austria, as well as in Belgium and Lithuania.  Around 55% of those asked said that the main reason for not wanting to get treatment in another country was that they were satisfied with the medical treatment they received in their own, while possible language difficulties were an issue for more than one quarter of those asked. And, not surprisingly, just under half of Europeans felt that “it was more convenient to be treated near home”.

In a strange choice of words, the report states that “lack of knowledge and awareness is not listed among the main reasons for not receiving treatment abroad today. Indeed, only 21% of the respondents who did not seek treatment abroad said that they ‘do not have enough information about the availability and quality of medical treatments abroad’.”

Please note and consider that phrase, “only 21%”.

In a 28-member state EU that figure “only” equates to more than 100 million potential patients who did not seek treatment abroad because they have a ‘lack of knowledge or awareness’ of cross-border treatment.

A little further into the report we learn that around the same number "do not have enough information about the availability and quality of medical treatments abroad".  The Brussels-based European Alliance for Personalised Medicine (EAPM) would very much like to highlight here the fact that 100 million is a great many people.

Later, the report concedes that patients only seem to have partial knowledge of their rights to cross-border health care, with less than 30% knowing that they can get a prescription from their doctor to use in another EU country. On top of this, only a ‘small minority’ knew when prior authorization was needed before seeking treatment in another EU country, with the legislation being complicated and differing from member state to member state.

The bottom-line is that most Europeans who were asked did not feel well-informed about the types of health care they have the right to be reimbursed for in another EU country – a massive 78%. Clearly, there are some large gaps in public knowledge and, doubtless, among GPs too.

Crucially, while 50% of those asked said they feel informed about their right to be reimbursed for healthcare in their own country, a staggering 80+% feel less-than-well informed about their rights when being treated in another EU country, with only one-in-ten having heard of the National Contact Point that provides information about EU cross-border health care.

For certain, there is no doubt that the provision of cross-border health services, reimbursement policies and coverage by national health-care systems is a highly complex affair, but nearly four-fifths of people not feeling well-informed is surely excessively high.  Meanwhile, the survey once again uses the word ‘only’ to describe the 15% of respondents who encountered problems getting reimbursed for cross-border treatments with the vast majority – 69% – saying they had had no problems getting reimbursed back home. Presumably, the missing 16% had at least some difficulties.

For example, Maria, a 28-year-old cancer sufferer from Valetta, told EAPM: “Not only did I have to dig out the information on where to go outside my own country, I also had considerable issues being reimbursed. It’s not easy in the first place to leave home for treatment, and this only makes it harder.”

And Finn, a 63-year-old from Copenhagen, revealed that he wasted more than a year hunting down treatment for his rare disease and lost time and quality of life “because I simply was not made aware of my options”.

EAPM strongly believes that the provision of cross-border health care is vital to giving the best treatment possible to all patients in the EU who need and want it, and that for its part the European Union should go much further down the line of encouraging member states to inform patients, and those who treat them, of their rights.

The Alliance believes that support to member states on streamlining their reimbursement procedures and making them more efficient, and with less red tape, is also an urgent requirement.  The facts about what works and what doesn’t in cross-border health care are in the report – it is time to act.

 

 

Europako Batzordeak

NextGenerationEU: Europako Batzordeak 231 milioi euro ordaindu dizkio Esloveniari aurrefinantzaketan

Argitaratutako

on

Europako Batzordeak 231 milioi euro eman dizkio Esloveniari aurrefinantzaketan, berreskuratzeko eta Errezilotzeko Instalazioak (RRF) emandako herrialdeko diru-laguntzaren% 13ren baliokidea. Aurrez finantzatutako ordainketak Esloveniaren susperraldi eta erresilientzia planean zehaztutako inbertsio eta erreforma neurri erabakigarriak ezartzen lagunduko du. Batzordeak Esloveniako berreskurapen eta erresilientzia planean zehaztutako inbertsioak eta erreformak gauzatzean oinarritutako beste ordainketa baimenduko du.

Herrialdeak 2.5 mila milioi euro jasoko ditu guztira, 1.8 mila milioi euroko laguntzetan eta 705 milioi euroko maileguetan, planaren bizitzan zehar. Gaurko ordainketa NextGenerationEUren baitan egindako lehen mailegu-eragiketak azkenaldian arrakastaz gauzatu ondoren. Urte amaierarako, Batzordearen asmoa da guztira 80 mila milioi euroko diru bilketa egitea epe luzerako, epe laburrerako EBko fakturekin osatzeko, NextGenerationEUren arabera estatu kideei aurreikusitako lehen ordainketak finantzatzeko.

RRF NextGenerationEUren muina da, 800 milioi euro emango ditu (egungo prezioetan) estatu kideetako inbertsioak eta erreformak laguntzeko. Esloveniako plana COVID-19 krisitik indartsuago ateratzeko aurrekaririk gabeko EBren erantzunaren parte da, trantsizio berdeak eta digitalak sustatuz eta gure gizarteetako sendotasuna eta kohesioa indartuz. A Prentsa-oharra eskuragarri online da.

iragarki

Jarraitu irakurtzen

Cyprus

NextGenerationEU: Europako Batzordeak 157 milioi euro ordaindu dizkio aurrez finantzatutako Zipri

Argitaratutako

on

Europako Batzordeak 157 milioi euro eman dizkio Zipri aurrefinantzaketan, berreskurapen eta erresilientzia tresnaren (RRF) herrialdeko finantza-zuzkiduraren% 13ren baliokidea. Aurrez finantzatutako ordainketak Zipreko berreskurapen eta erresilientzia planean zehaztutako inbertsio eta erreforma neurri erabakigarriak ezartzen lagunduko du. Batzordeak Zipreko berreskurapen eta erresilientzia planean zehaztutako inbertsioak eta erreformak gauzatzean oinarritutako beste ordainketa baimenduko du.

Herrialdeak 1.2 mila milioi euro jasoko ditu guztira bere planean zehar, 1 mila milioi euro laguntzetan eta 200 milioi euro maileguetan emango dira. Gaurko ordainketa NextGenerationEUren lehen mailegu-eragiketak azkenaldian arrakastaz gauzatu ondoren. Urte amaierarako, Batzordearen asmoa da guztira 80 milioi euro biltzea epe luzeko finantzaketan, epe laburreko EBko fakturekin osatzeko, NextGenerationEUren arabera estatu kideei aurreikusitako lehen ordainketak finantzatzeko. NextGenerationEUren zati denez, RRFk 723.8 milioi euro emango ditu (egungo prezioetan), estatu kideetako inbertsioak eta erreformak laguntzeko.

Zipreko plana COVID-19 krisitik indartsuago ateratzeko aurrekaririk gabeko EBren erantzunaren parte da, trantsizio berdeak eta digitalak sustatuz eta gure gizarteetako sendotasuna eta kohesioa indartuz. A Prentsa-oharra eskuragarri online da.

iragarki

Jarraitu irakurtzen

Belgikan

EBko Kohesio politika: Belgikak, Alemaniak, Espainiak eta Italiak 373 milioi euro jaso dituzte osasun eta gizarte zerbitzuei, ETEei eta gizarteratzeari laguntzeko

Argitaratutako

on

Batzordeak 373 milioi euro eman dizkie bostei Europako Gizarte Funtsak (ESF) eta Eskualde Garapeneko Europako Funtsak (EGEF) programa operatiboak (OP) Belgikan, Alemanian, Espainian eta Italian, koronabirusaren larrialdiei erantzuteko eta konpontzeko arazoak dituzten herrialdeei laguntzeko REACT-EB. Belgikan, Valoniako OP aldaketak 64.8 milioi euro gehiago jarriko ditu eskuragarri osasun zerbitzuetarako eta berrikuntzarako ekipamendu medikoa eskuratzeko.

Funtsak enpresa txiki eta ertainei (ETEei) lagunduko die merkataritza elektronikoa, zibersegurtasuna, webguneak eta lineako dendak garatzen, baita eskualdeko ekonomia berdea ere energia-eraginkortasunaren, ingurumenaren babesaren, hiri adimendunen garapenaren eta karbono gutxiko garapenaren bidez. azpiegitura publikoak. Alemanian, Hessen Estatu Federalean, 55.4 milioi euro lagunduko ditu osasunarekin lotutako ikerketa azpiegiturak, diagnostiko gaitasuna eta berrikuntza unibertsitateetan eta beste ikerketa erakunde batzuetan, baita klima eta garapen iraunkorraren alorreko ikerketa, garapen eta berrikuntza inbertsioak ere. Aldaketa honen bidez, laguntza emango zaie ETEei eta inbertsio funts baten bidez hasiberrientzako funtsak.

Sachsen-Anhalt-en, 75.7 milioi euro ETEek eta erakundeek lankidetza erraztuko dute ikerketan, garapenean eta berrikuntzan, eta inbertsioak eta kapital aktiboa eskaintzea koronabirusaren krisiak eragindako mikroenpresei. Gainera, funtsak enpresen energia eraginkortasunean inbertsioak egitea ahalbidetuko dute, ETEen berrikuntza digitala lagunduko dute eta ikastetxe eta kultur erakundeentzako ekipamendu digitala eskuratuko dute. Italian, "Gizarteratzea" PO nazionalak 90 milioi euro jasoko ditu gabezia material larria, etxegabetzeak edo muturreko marjinazioa jasaten duten pertsonen gizarteratzea sustatzeko, berehalako etxebizitza eskaintzea eta gizarte eta enplegu zerbitzuak ahalbidetzen dituzten "Housing First" zerbitzuen bidez. .

iragarki

Espainian, 87 milioi euro gehituko zaizkio Gaztela eta Leongo FSE POari, krisiaren ondorioz kontratuak eten edo murriztu zituzten autonomoei eta langileei laguntzeko. Diruari esker, kalte handiko enpresek kaleratzeak saihesten lagunduko dute, batez ere turismoaren sektorean. Azkenean, funtsezkoak dira funtsezko gizarte zerbitzuek modu seguru batean jarrai dezaten eta pandemia osoan hezkuntza jarraitasuna bermatzeko langile osagarriak kontratatuz.

REACT-EU-ren parte da NextGenerationEU eta 50.6 mila milioi euroko finantzazio gehigarria eskaintzen du (egungo prezioetan) Kohesio politikako programetarako 2021 eta 2022. urteetan zehar. Neurriak lan merkatuko erresilientziari, lanpostuei, ETEei eta diru sarrera baxuetako familiei laguntzeaz gain, etorkizuneko oinarriak finkatzea da. trantsizio berdeak eta digitalak eta suspertze sozioekonomiko iraunkorra.

iragarki

Jarraitu irakurtzen
iragarki
iragarki
iragarki

Modako